V Polin - JoVE Visualize

Showing results (1-10 of 8) with videos related to

Pageof 1

Sort By:

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 1, 1997

Do noradrenaline and serotonin differentially affect social motivation and behaviour?A Dubini, M Bosc, V Polin

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 1, 1997

Development and validation of a social functioning scale, the Social Adaptation Self-evaluation ScaleM Bosc, A Dubini, V Polin

Journal of Psychopharmacology (Oxford, England)|January 1, 1997

Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioningA Dubini, M Bosc, V Polin

Hematology and Cell Therapy|October 1, 1996

Treatment of acute myeloblastic leukemia in adults. The GOELAM experienceJ L Harousseau, B Pignon, F Witz, et al.

Gut|July 24, 2009

Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's diseaseH Sokol, V Polin, A Lavergne-Slove, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997

Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III studyJ L Pujol, J Y Douillard, A Rivière, et al.

Blood|May 16, 1998

A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM)F Witz, A Sadoun, M C Perrin, et al.

British Journal of Haematology|August 1, 1996

Treatment of acute myelogenous leukaemia in patients aged 50-65: idarubicin is more effective than zorubicin for remission induction and prolonged disease-free survival can be obtained using a unique consolidation course. The Goelam GroupB Pignon, F Witz, B Desablens, et al.

Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:

Pageof 1

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 1, 1997

Do noradrenaline and serotonin differentially affect social motivation and behaviour?A Dubini, M Bosc, V Polin

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 1, 1997

Development and validation of a social functioning scale, the Social Adaptation Self-evaluation ScaleM Bosc, A Dubini, V Polin

Journal of Psychopharmacology (Oxford, England)|January 1, 1997

Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioningA Dubini, M Bosc, V Polin

Hematology and Cell Therapy|October 1, 1996

Treatment of acute myeloblastic leukemia in adults. The GOELAM experienceJ L Harousseau, B Pignon, F Witz, et al.

Gut|July 24, 2009

Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's diseaseH Sokol, V Polin, A Lavergne-Slove, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997

Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III studyJ L Pujol, J Y Douillard, A Rivière, et al.

Blood|May 16, 1998

A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM)F Witz, A Sadoun, M C Perrin, et al.

British Journal of Haematology|August 1, 1996

Treatment of acute myelogenous leukaemia in patients aged 50-65: idarubicin is more effective than zorubicin for remission induction and prolonged disease-free survival can be obtained using a unique consolidation course. The Goelam GroupB Pignon, F Witz, B Desablens, et al.

Pageof 1